{"componentChunkName":"component---src-templates-topic-topic-tsx","path":"/topics/cervical-screening/","result":{"data":{"firstChapter":{"id":"2fe43b2a-0956-5a22-a141-2c23ff8702d1","slug":"summary","fullItemName":"Summary","subChapters":[],"depth":1,"htmlHeader":"<!-- begin field 8543e5b1-5eec-45d1-8310-6e08de60ecae --><h1>Cervical screening: Summary</h1><!-- end field 8543e5b1-5eec-45d1-8310-6e08de60ecae -->","htmlStringContent":"<!-- begin item 1900d4a8-51b8-43e0-956b-f65f34bed259 --><!-- begin field 3e48a364-84c0-4d94-b48b-65d0fad92510 --><ul><li>Cervical screening aims to reduce the incidence of, and mortality from, cervical cancer through a systematic, quality assured population-based screening programme for eligible women. <ul><li>Cervical screening is not a test for cancer.</li></ul></li><li>The NHS Cervical Screening Programme (NHSCSP) is nationally coordinated and locally managed. It involves:<ul><li>Primary human papillomavirus (HPV) screening.</li><li>Liquid based cytology to detect abnormalities of the cervix.</li><li>Colposcopy to diagnose cervical intraepithelial neoplasia (CIN) and to differentiate high-grade lesions from low-grade abnormalities.</li></ul></li><li>The primary care practice is responsible for encouraging women to attend for screening and taking cervical cytology samples.</li><li>The laboratory is responsible for:<ul><li>Performing HPV testing and screening cervical samples.</li><li>Sending results to the woman's GP and ensuring that all abnormal results are followed up.</li></ul></li><li>The colposcopy service role includes:<ul><li>Accepting direct referrals from the laboratory and the GPs as appropriate.</li><li>Investigating and treating women with abnormal results. </li><li>Following up treatment with further investigations as appropriate.</li><li>Discharging the woman back to the call and recall system.</li><li>Running a fail-safe system to ensure follow-up of all women who have been treated.</li></ul></li><li>Screening should be offered to all women aged 24.5–64 years. Women aged:<ul><li>24.5 years should receive their first invitation to ensure they can be screened before they are aged 25 years.</li><li>25–49 years should be offered screening every 3 years.</li><li>50–64 years should be offered screening every 5 years.</li></ul></li><li>Women 65 years of age or older should be screened if:<ul><li>A recent cervical cytology sample is abnormal.</li><li>They have not had a cervical screening test since 50 years of age and they request one.</li></ul></li><li>Women with cervical stenosis, or a cervix that cannot be visualized should be referred for colposcopy.</li><li>During pregnancy:<ul><li>Routine screening should be rescheduled until the woman is at least 12 weeks post-partum.</li><li>If a previous test was abnormal and in the interim the woman becomes pregnant, colposcopy should not be delayed.</li></ul></li><li>Individuals who are high-risk HPV (hrHPV) negative should be returned to routine recall and individuals who are hrHPV positive should be managed depending on cytology results. </li><li>Individuals who are hrHPV positive and receive a negative cytology report should have the HPV test repeated at 12 months.<ul><li>If HPV testing is negative at 12 months, individuals can be safely returned to routine recall.</li><li>Individuals who remain hrHPV positive, cytology negative at 12 months should have a repeat HPV test in a further 12 months. Individuals who become hrHPV negative at 24 months can be safely returned to routine recall.</li><li>Individuals who remain hrHPV positive, cytology negative or inadequate at 24 months should be referred to colposcopy.</li></ul></li><li>Individuals who remain hrHPV positive with cytology reported as borderline dyskaryosis or worse at 12 or 24 months should be referred to colposcopy.</li><li>All individuals who are hrHPV positive and have abnormal cytology should be referred to colposcopy. </li></ul><!-- end field 3e48a364-84c0-4d94-b48b-65d0fad92510 --><!-- end item 1900d4a8-51b8-43e0-956b-f65f34bed259 -->","topic":{"id":"6eb2d6d6-d121-574a-8070-e380a54d0dd0","topicId":"7394dee4-4555-4874-bb15-5ac5d86ed7d9","topicName":"Cervical screening","slug":"cervical-screening","aliases":[],"chapters":[{"id":"2fe43b2a-0956-5a22-a141-2c23ff8702d1","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"5da2ce64-4373-5a2d-a1a6-3f3bbdf2bf7c","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"7b70a539-14d0-50b6-93cc-edbf89ec4bc3","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"576d9368-458f-5490-8bdf-666b91a7e37a","slug":"changes","fullItemName":"Changes"},{"id":"bcd50065-ad13-5af2-8473-de68a499f070","slug":"update","fullItemName":"Update"}]},{"id":"c2a0a95f-2a9b-5c96-a2b0-d26471380d35","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"8e98fda8-7c58-5f08-8d78-770e7406cc2b","slug":"goals","fullItemName":"Goals"},{"id":"aac1adb6-9e3a-50e6-976b-3d8be05b4f28","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"b4286b35-0cba-5c8d-b4c0-55905649e5ef","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"32c01e99-78fd-50ce-a1b4-3fd4edcb1ecb","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"d0510235-ec88-5b0a-9a2e-4ad7888d78be","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"5c4e6833-b040-537b-a32b-54b1317aa217","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"b8be2709-4f11-5914-bcf3-e1a1d79fd23f","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"6d7d120d-e785-5601-9d0e-e08e28d89528","slug":"cervical-screening-programme","fullItemName":"Cervical screening programme"},{"id":"b6a7bd00-5536-5a5d-b7f3-fe1ac9685d22","slug":"cervical-screening-system","fullItemName":"Cervical screening system"}]},{"id":"5cc77439-27cd-51ff-9a06-857c9da72416","slug":"management","fullItemName":"Management","subChapters":[{"id":"ba0780ef-6124-5552-b202-75eebabe99e3","slug":"cervical-screening","fullItemName":"Scenario: Cervical screening"},{"id":"cb3f22ee-57b6-5cf4-aed8-3471ae0e9a9c","slug":"managing-hpv-cervical-cytology-results","fullItemName":"Scenario: Managing HPV and cervical cytology results"}]},{"id":"a5410c1d-84f3-5826-8512-481fd075d2a9","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"5aade9cf-191d-5481-a6fc-cc57568100f2","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"2e666af8-5f3b-576d-b97c-d4a65b6bb80e","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"b3806c5f-8045-5cf8-a395-aea0d965082b","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"df251649-2597-5c2e-8fb1-5740228d0346","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"58fed207-e499-59b9-99ec-0b1dd974fe5e","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"26cba24b-2a00-54c4-b253-3e851f0fbcba","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"7cf3b493-5fcc-5741-878b-5f094a762815","slug":"references","fullItemName":"References","subChapters":[]}]}},"topic":{"id":"6eb2d6d6-d121-574a-8070-e380a54d0dd0","topicId":"7394dee4-4555-4874-bb15-5ac5d86ed7d9","topicName":"Cervical screening","slug":"cervical-screening","aliases":[],"topicSummary":"Cervical screening aims to reduce the incidence of, and mortality from, cervical cancer by systematic, quality assured population-based screening","lastRevised":"Last revised in September 2020","nextPlannedReviewBy":"2022-08-01T00:00:00+01:00","nextPlannedReviewByDateTime":"2022-07","nextPlannedReviewByDisplay":"July 2022","specialities":[{"id":"2454765b-1b2d-53fc-b288-17b66486f41a","name":"Preventative medicine","slug":"preventative-medicine"},{"id":"0c813417-9691-5826-9371-c4bec6c53f06","name":"Women's health","slug":"womens-health"}],"chapters":[{"id":"2fe43b2a-0956-5a22-a141-2c23ff8702d1","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"5da2ce64-4373-5a2d-a1a6-3f3bbdf2bf7c","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"7b70a539-14d0-50b6-93cc-edbf89ec4bc3","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"576d9368-458f-5490-8bdf-666b91a7e37a","slug":"changes","fullItemName":"Changes"},{"id":"bcd50065-ad13-5af2-8473-de68a499f070","slug":"update","fullItemName":"Update"}]},{"id":"c2a0a95f-2a9b-5c96-a2b0-d26471380d35","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"8e98fda8-7c58-5f08-8d78-770e7406cc2b","slug":"goals","fullItemName":"Goals"},{"id":"aac1adb6-9e3a-50e6-976b-3d8be05b4f28","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"b4286b35-0cba-5c8d-b4c0-55905649e5ef","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"32c01e99-78fd-50ce-a1b4-3fd4edcb1ecb","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"d0510235-ec88-5b0a-9a2e-4ad7888d78be","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"5c4e6833-b040-537b-a32b-54b1317aa217","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"b8be2709-4f11-5914-bcf3-e1a1d79fd23f","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"6d7d120d-e785-5601-9d0e-e08e28d89528","slug":"cervical-screening-programme","fullItemName":"Cervical screening programme"},{"id":"b6a7bd00-5536-5a5d-b7f3-fe1ac9685d22","slug":"cervical-screening-system","fullItemName":"Cervical screening system"}]},{"id":"5cc77439-27cd-51ff-9a06-857c9da72416","slug":"management","fullItemName":"Management","subChapters":[{"id":"ba0780ef-6124-5552-b202-75eebabe99e3","slug":"cervical-screening","fullItemName":"Scenario: Cervical screening"},{"id":"cb3f22ee-57b6-5cf4-aed8-3471ae0e9a9c","slug":"managing-hpv-cervical-cytology-results","fullItemName":"Scenario: Managing HPV and cervical cytology results"}]},{"id":"a5410c1d-84f3-5826-8512-481fd075d2a9","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"5aade9cf-191d-5481-a6fc-cc57568100f2","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"2e666af8-5f3b-576d-b97c-d4a65b6bb80e","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"b3806c5f-8045-5cf8-a395-aea0d965082b","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"df251649-2597-5c2e-8fb1-5740228d0346","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"58fed207-e499-59b9-99ec-0b1dd974fe5e","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"26cba24b-2a00-54c4-b253-3e851f0fbcba","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"7cf3b493-5fcc-5741-878b-5f094a762815","slug":"references","fullItemName":"References","subChapters":[]}]}},"pageContext":{"id":"6eb2d6d6-d121-574a-8070-e380a54d0dd0"}},"staticQueryHashes":["3666801979"]}